
Overview
Background
Operations Manager - National Biologics Facility
Deputy Director - ARC Training Centre for Biopharmaceutical Innovation
Research Areas: Discovery and engineering of antibodies for diagnostic or therapeutic uses
BScApp (Biotech) Honours Class I (1998) The University of Queensland
PhD (2008) The University of Queensland
Availability
- Dr Martina Jones is:
- Available for supervision
Fields of research
Qualifications
- Bachelor (Honours) of Applied Science, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Martina Jones’s works on UQ eSpace
2000
Conference Publication
Stability of labile folate is enhanced by binding milk folate-binding protein
Hutchinson, M. L., Jones, M. and Nixon, P. F. (2000). Stability of labile folate is enhanced by binding milk folate-binding protein. Dairy Ingredient Science 2000 Conference, Melbourne, Australia, 28-30 Jun, 2000. Melbourne, Australia: Dairy Industry Association of Australia.
Funding
Current funding
Supervision
Availability
- Dr Martina Jones is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Engineering Novel Theranostics for High Grade Glioma Through Site-Specific EphA2 Antibody Modification
Principal Advisor
Other advisors: Emeritus Professor Stephen Mahler, Dr Christopher Howard
-
Doctor Philosophy
From Target Discovery to Therapeutic Antibodies
Associate Advisor
Other advisors: Dr Lucia Zacchi, Professor Jessica Mar
Completed supervision
-
2022
Doctor Philosophy
Investigating monoclonal antibody targets on P. falciparum and red blood cell antigens using experimental mouse model and phage display technology
Principal Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2021
Doctor Philosophy
An investigation of human antibodies to blood group antigens for the management of haemolytic disease of the fetus and newborn
Principal Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2021
Doctor Philosophy
The Isolation and Characterisation of Novel Antibodies Against the Murine Beta Common Receptor Using Two Methods of Phage Display Biopanning
Principal Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2021
Doctor Philosophy
Structural Studies of MNS Glycophorins to Guide the Discovery of Monoclonal Antibodies
Principal Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2023
Doctor Philosophy
Discovery and Development of a Novel Human Glypican-1 Monoclonal Antibody for Targeting Solid Cancers
Associate Advisor
Other advisors: Emeritus Professor Stephen Mahler, Dr Christopher Howard
-
2022
Doctor Philosophy
Development of monoclonal antibodies against human neutrophil antigen 3 (HNA-3)
Associate Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2020
Doctor Philosophy
Development of novel bioconjugation strategies for creating cancer-targeting nanomaterials
Associate Advisor
Other advisors: Emeritus Professor Stephen Mahler, Dr Christopher Howard
-
2019
Doctor Philosophy
Developing antibody-based therapy to treat acute Epstein-Barr virus infection and prevent its associated diseases
Associate Advisor
-
2019
Doctor Philosophy
Isolation and characterisation of antibodies against human and canine EphA2_ targets for comparative studies in brain cancer
Associate Advisor
Other advisors: Professor Andrew Whittaker, Dr Christopher Howard, Emeritus Professor Stephen Mahler
-
2018
Doctor Philosophy
Isolation and development of antibodies for active targeting of nanocells for cancer therapy
Associate Advisor
Other advisors: Dr Christopher Howard, Emeritus Professor Stephen Mahler
-
2017
Doctor Philosophy
Development and Application of Novel Biosensor Technologies
Associate Advisor
Other advisors: Dr Christopher Howard, Emeritus Professor Stephen Mahler
-
2015
Doctor Philosophy
Development of monoclonal antibodies as tools for analysis of PTPRJ function.
Associate Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2015
Doctor Philosophy
Engineering bispecific antibodies for targeted delivery of cytotoxin-loaded nanoparticles to tumour cells
Associate Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2015
Doctor Philosophy
Antibody Discovery for Development of a Serotyping Dengue Virus NS1 Capture Assay
Associate Advisor
Other advisors: Emeritus Professor Stephen Mahler
-
2015
Doctor Philosophy
Design, Assembly and Characterisation of a Multifunctional, Self-Assembled Nanoparticle incorporating Antibody Fragments
Associate Advisor
Other advisors: Emeritus Professor Stephen Mahler, Professor Kristofer Thurecht
Media
Enquiries
For media enquiries about Dr Martina Jones's areas of expertise, story ideas and help finding experts, contact our Media team: